RecruitingNCT07111663

An Observational Study of Individuals With Isolated Dystonia


Sponsor

Vima Therapeutics

Enrollment

200 participants

Start Date

Jun 17, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This is an observational study in individuals with isolated (or primary) dystonia that involves more than one body region. The purpose of the study is to collect detailed information to help your physician and other researchers understand how dystonia impacts your and other patients' lives and how the disease changes over time. The study may also help researchers better understand the clinical scales that are commonly used to evaluate dystonia symptoms and how they affect various areas of life such as well-being, pain, relationships and social interactions, and progress over time. Because this is an observational study, you will not receive any interventional treatment in the study.


Eligibility

Min Age: 12 YearsMax Age: 65 Years

Inclusion Criteria3

  • The participant is willing to sign an informed consent form indicating that he/she understands the purpose of the study; understands and can perform, complete, and comply with all the assessments that are required during the study; and is willing to participate in the study.
  • The participant is a male or female between 12 and 65 years of age (inclusive).
  • The participant has a clinical diagnosis of isolated (or primary) dystonia for at least one year prior to Visit 1 and meets the study definition of segmental/multifocal or generalized dystonia at Visit 1.

Exclusion Criteria7

  • The participant has a diagnosis of focal dystonia at Visit 1.
  • The participant has a diagnosis of dopa-responsive dystonia, secondary dystonia, or psychogenic/functional dystonia.
  • The participant has any significant ongoing disease, disorder, laboratory abnormalities, alcohol or illicit drug abuse or dependence, environmental factor, or any ongoing or history of any medical or surgical condition that in the judgment of the investigator, in consultation with the medical monitor and/or sponsor's designee, might jeopardize the participant's safety, impact the scientific objectives of the clinical study, or interfere with participation in the clinical study.
  • The participant has a history of any psychiatric or cognitive impairment disorder that, in the opinion of the investigator, may interfere with study conduct.
  • The participant has had myotomy or denervation surgery in any affected muscles (e.g., peripheral denervation and/or spinal cord stimulation).
  • The participant has marked limitation on passive range of motion that suggests contractures or other structural abnormality (e.g., cervical contractures or cervical spine syndrome).
  • The participant has undergone deep brain stimulation (DBS) surgery (even if implant deactivated).

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(29)

Vima Site #004

Scottsdale, Arizona, United States

Vima Site #028

Sun City, Arizona, United States

Vima Site #010

Aliso Viejo, California, United States

Vima Site #030

Los Angeles, California, United States

Vima Site #022

Palo Alto, California, United States

Vima Site #019

Englewood, Colorado, United States

Vima Site #003

Boca Raton, Florida, United States

Vima Site #009

Gainesville, Florida, United States

Vima Site #008

Miami, Florida, United States

Vima Site #031

Orlando, Florida, United States

Vima Site #005

Atlanta, Georgia, United States

Vima Site #027

Chicago, Illinois, United States

Vima Site #007

Olney, Maryland, United States

Vima Site #002

Farmington Hills, Michigan, United States

Vima Site #014

Albuquerque, New Mexico, United States

Vima Site #017

Commack, New York, United States

Vima Site #018

New York, New York, United States

Vima Site #024

New York, New York, United States

Vima Site #029

Portland, Oregon, United States

Vima Site #020

Philadelphia, Pennsylvania, United States

Vima Site #021

Charleston, South Carolina, United States

Vima Site #016

Memphis, Tennessee, United States

Vima Site #006

Nashville, Tennessee, United States

Vima Site #025

Dallas, Texas, United States

Vima Site #026

Georgetown, Texas, United States

Vima Site #012

Houston, Texas, United States

Vima Site #011

Richmond, Virginia, United States

Vima Site #023

Kirkland, Washington, United States

Vima Site #015

Spokane, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07111663